Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th World Stroke Congress in October

Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) for critical care indications, announced today their participation in two October conferences, the 2022 Cell & Gene Meeting on the Mesa on October 11-13, 2022 and the 14^th World Stroke Congress on October 26-29, 2022.

Dr. Robert W. Mays, Executive Vice President and Head of Regenerative Medicine & Neuroscience, will present live at the 2022 Cell & Gene Meeting on the Mesa in Carlsbad, California on October 11. Dr. Mays will provide a corporate overview of the Company’s therapeutic MultiStem cellular therapy, and an update on preclinical and clinical perspectives utilizing the MultiStem cellular platform technology to date. The presentation will provide an overview of the Company’s ongoing clinical studies in ischemic stroke, acute respiratory distress syndrome and trauma. Mr. Dan Camardo, Chief Executive Officer, Ms. Maia Hansen, Chief Operating Officer, and Dr. Sarah Busch, Vice President of Regenerative Medicine and Head of Non-Clinical Development, will also be in attendance from October 11-13 to meet with registered attendees.

Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference that brings together senior executives and top decision-makers in the industry to highlight technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.

The following are specific details regarding the Athersys presentation at the Cell & Gene Meeting on the Mesa conference:

Event:	The 2022 Cell & Gene Meeting on the Mesa
Date:	Tuesday, October 11, 2022
Time:	4:00 PM Pacific Time
Location:	Oxford Biomedica Ballroom, Park Hyatt Aviara Resort, Carlsbad, CA

A live video webcast of all company presentations and sessions will be available for registered participants and will also be published on the conference website after the event concludes. In addition, a webcast of the corporate presentation by Dr. Mays will be posted on the investor section of www.athersys.com when it becomes available. Please visit www.meetingonthemesa.com for detailed conference information and registration.